AdiposeDown XL [5-Amino-1MQ - 500 mg] - 10 Vials - Corey Pauling

Laboratory: Corey Pauling
Form: Subcutaneous injection
Molecule: 5-Amino-1MQ (5-Amino-1-methylquinolinium)
Concentration: 50mg/vial
Volume: 10 vials
AdiposeDown XL [50mg] contains 5-Amino-1MQ, a small-molecule NNMT inhibitor studied for its potential effects on fat metabolism, metabolic efficiency, NAD+ metabolism, and body composition. It is particularly relevant to athletes and bodybuilding practitioners during cutting and recomposition phases, alongside a structured diet and training program.

Description and Effects

ADIPOSEDOWN XL [5-Amino-1MQ 50mg] contains 5-Amino-1-methylquinolinium (5-Amino-1MQ), a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT plays a role in nicotinamide metabolism and cellular methylation, making 5-Amino-1MQ an interesting compound in metabolic and body-composition research. For athletes and bodybuilding practitioners, it is primarily studied for its potential to support fat metabolism, metabolic efficiency, energy expenditure, and body recomposition during cutting phases.

Product Benefits

• Fat Metabolism Support: Studied for its potential to influence adipose tissue metabolism and support pathways involved in fat utilization.
• Metabolic Support: NNMT inhibition may influence cellular energy metabolism and metabolic efficiency.
• Body Recomposition: Its metabolic properties make 5-Amino-1MQ particularly interesting during cutting and recomposition phases.
• NAD+ Metabolism: NNMT inhibition may help preserve nicotinamide availability and support intracellular NAD+ metabolism.
• Cutting Support: Particularly relevant for athletes looking to complement a structured calorie deficit, training program, and body-composition strategy.

Usage Guidelines

• Reference Protocol: 2.5 to 5mg per day by subcutaneous injection is commonly reported in research-oriented protocols.
• Standard Approach: 5mg once daily is a commonly referenced research dose following an initial tolerance period.
• Split Protocol: 2.5mg twice daily may be used instead of a single 5mg administration.
• Higher Research Protocols: Some sources report doses above 5mg per day, including 5mg twice daily.
• Timing: Administration may be performed in the morning or divided between morning and evening when using a split protocol.
• Administration: Subcutaneous injection.

Precautions and Wellness

• Possible Side Effects: Headache, nausea, digestive discomfort, fatigue, appetite changes, or injection-site reactions may occur.
• Tolerance: Starting at the lower end of the range allows individual tolerance to be assessed before increasing the daily amount.
• Monitoring: Monitor body weight, body composition, appetite, energy levels, and general tolerance throughout use.
• Research Status: 5-Amino-1MQ does not currently have an established clinically validated human dosage. Available protocols are research-oriented and vary considerably between sources.
• Storage: Store the lyophilized product according to the manufacturer's instructions. After reconstitution, refrigerate and protect from light.